September 24, 2017 9:55 PM ET


Company Overview of Tetraphase Pharmaceuticals, Inc.

Executive Profile

Maria D. Stahl

Senior Vice President and General Counsel, Tetraphase Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Member in 0 organization across 3 different industries.

As of Fiscal Year 2016


Ms. Maria D. Stahl has been Senior Vice President and General Counsel of Tetraphase Pharmaceuticals, Inc. since March 5, 2015. Prior to Tetraphase, Ms. Stahl served as Senior Vice President, General Counsel and Secretary of Idenix Pharmaceuticals, Inc. from October 2010 to August 2014. Prior to rejoining Idenix, Ms. Stahl served as General Counsel of Zipcar, Inc. from November 2009 to October 2010. She also served as Idenix’s Vice President, Associate General Counsel ...

Corporate Headquarters

480 Arsenal Street
Watertown, Massachusetts 02472

United States

Phone: 617-715-3600
Fax: 617-926-3557

Board Members Memberships

There is no Board Members Memberships data available.


Providence College
Yale Law School

Other Affiliations

Annual Compensation

Total Annual Compensation$340,000

Stocks Options

Restricted Stock Awards$254,100
All Other Compensation$9,464
Exercisable Options$69,688
Unexercisable Options$135,312
Total Number of Options$205,000

Total Compensation

Total Annual Cash Compensation$456,564
Total Short Term Compensation$340,000
Other Long Term Compensation$263,564
Total Calculated Compensation$1,205,832

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tetraphase Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at